Type II transmembrane serine proteases
- PMID: 19487698
- PMCID: PMC2749090
- DOI: 10.1074/jbc.R109.021006
Type II transmembrane serine proteases
Abstract
Analysis of genome and expressed sequence tag data bases at the turn of the millennium unveiled a new protease family named the type II transmembrane serine proteases (TTSPs) in a Journal of Biological Chemistry minireview (Hooper, J. D., Clements, J. A., Quigley, J. P., and Antalis, T. M. (2001) J. Biol. Chem. 276, 857-860). Since then, the number of known TTSPs has more than doubled, and more importantly, our understanding of the physiological functions of individual TTSPs and their contribution to human disease has greatly increased. Progress has also been made in identifying molecular substrates and endogenous inhibitors. This minireview summarizes the current knowledge of the rapidly advancing TTSP field.
Figures
Similar articles
-
Expression and genetic loss of function analysis of the HAT/DESC cluster proteases TMPRSS11A and HAT.PLoS One. 2011;6(8):e23261. doi: 10.1371/journal.pone.0023261. Epub 2011 Aug 10. PLoS One. 2011. PMID: 21853097 Free PMC article.
-
TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.FEBS J. 2010 Dec;277(23):4888-900. doi: 10.1111/j.1742-4658.2010.07894.x. Epub 2010 Oct 26. FEBS J. 2010. PMID: 20977675
-
TMPRSS4 is a type II transmembrane serine protease involved in cancer and viral infections.Biol Chem. 2012 Sep;393(9):907-14. doi: 10.1515/hsz-2012-0155. Biol Chem. 2012. PMID: 22944691 Review.
-
The role of type II transmembrane serine protease-mediated signaling in cancer.FEBS J. 2017 May;284(10):1421-1436. doi: 10.1111/febs.13971. Epub 2016 Dec 24. FEBS J. 2017. PMID: 27870503 Free PMC article. Review.
-
Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and -2-mediated cell-surface localization.J Biol Chem. 2017 Sep 8;292(36):14867-14884. doi: 10.1074/jbc.M117.775999. Epub 2017 Jul 14. J Biol Chem. 2017. PMID: 28710277 Free PMC article.
Cited by
-
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency.bioRxiv [Preprint]. 2024 Aug 29:2024.08.28.609965. doi: 10.1101/2024.08.28.609965. bioRxiv. 2024. PMID: 39257753 Free PMC article. Preprint.
-
Transmembrane serine protease 4 expression in the prognosis of radical resection for biliary tract cancer.World J Gastrointest Surg. 2024 Aug 27;16(8):2555-2564. doi: 10.4240/wjgs.v16.i8.2555. World J Gastrointest Surg. 2024. PMID: 39220090 Free PMC article.
-
Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin.Protein Sci. 2024 Aug;33(8):e5110. doi: 10.1002/pro.5110. Protein Sci. 2024. PMID: 39073183
-
Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects.Mar Life Sci Technol. 2024 Feb 21;6(2):280-297. doi: 10.1007/s42995-023-00215-9. eCollection 2024 May. Mar Life Sci Technol. 2024. PMID: 38827130 Review.
-
Effects of transmembrane serine protease 4 on the survival in patients with pancreatic ductal adenocarcinoma undergoing surgery followed by adjuvant chemotherapy.Surg Today. 2024 Oct;54(10):1208-1219. doi: 10.1007/s00595-024-02824-y. Epub 2024 Apr 19. Surg Today. 2024. PMID: 38637344
References
-
- Hooper J. D., Clements J. A., Quigley J. P., Antalis T. M. (2001) J. Biol. Chem. 276,857–860 - PubMed
-
- Szabo R., Wu Q., Dickson R. B., Netzel-Arnett S., Antalis T. M., Bugge T. H. (2003) Thromb. Haemost. 90,185–193 - PubMed
-
- Szabo R., Bugge T. H. (2008) Int. J. Biochem. Cell Biol. 40,1297–1316 - PubMed
-
- Takeuchi T., Harris J. L., Huang W., Yan K. W., Coughlin S. R., Craik C. S. (2000) J. Biol. Chem. 275,26333–26342 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources